Author:
Wang Sha-sha,Peng Ye,Fan Ping-long,Ye Jun-rui,Ma Wen-yu,Wu Qing-lin,Wang Hong-yun,Tian Ya-juan,He Wen-bin,Yan Xu,Zhang Zhao,Chu Shi-feng,Chen Nai-hong
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Przedborski S. The two-century journey of Parkinson disease research. Nat Rev Neurosci. 2017;18:251–9.
2. Emamzadeh FN, Surguchov A. Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018;12:612.
3. Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, et al. Trial of cinpanemab in early Parkinson’s disease. N Engl J Med. 2022;387:408–20.
4. Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, et al. Trial of prasinezumab in early-stage Parkinson’s disease. N Engl J Med. 2022;387:421–32.
5. Zou K, Guo W, Tang G, Zheng B, Zheng Z. A case of early onset Parkinson’s disease after major stress. Neuropsychiatr Dis Treat. 2013;9:1067–9.